BrioPryme Biologics, Inc. crafts innovative and effective biosurgical products utilizing animal tissues and their derivatives. Our pipeline forms a robust portfolio of products in management of chemoradiotherapy-induced skin and mucous membrane toxicity, oral and denture wounds, ocular surface wounds and dry eye disease.